{"id":"NCT01307046","sponsor":"Organon and Co","briefTitle":"MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)","officialTitle":"A Phase III, Randomized, Active-comparator Controlled Clinical Trial to Study the Efficacy and Safety of MK-0954A in Japanese Patients With Essential Hypertension Uncontrolled With the High Dose of Losartan Potassium","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-03-29","primaryCompletion":"2012-02-07","completion":"2012-02-07","firstPosted":"2011-03-02","resultsPosted":"2013-03-22","lastUpdate":"2024-05-17"},"enrollment":336,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"MK-0954A","otherNames":[]},{"type":"DRUG","name":"Losartan","otherNames":[]},{"type":"DRUG","name":"Placebo to MK-0954A","otherNames":[]},{"type":"DRUG","name":"Placebo to losartan 100 mg","otherNames":[]},{"type":"DRUG","name":"Placebo to losartan 50 mg","otherNames":[]}],"arms":[{"label":"MK-0954A","type":"EXPERIMENTAL"},{"label":"Losartan","type":"ACTIVE_COMPARATOR"}],"summary":"This study is being conducted to evaluate the efficacy of MK-0954A in essential hypertension participants who are not adequately controlled with losartan.","primaryOutcome":{"measure":"Change From Baseline in Trough Sitting Diastolic Blood Pressure (SiDBP)","timeFrame":"Baseline and Week 8","effectByArm":[{"arm":"MK-0954A","deltaMin":-8.7,"sd":0.6},{"arm":"Losartan","deltaMin":-3.6,"sd":0.6}],"pValues":[{"comp":"OG000 vs OG001","p":"<.001"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24990091"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":166},"commonTop":["Nasopharyngitis"]}}